Purple Biotech Ltd. (PPBT) stock
PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.71+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.59MP/E 0.0Yield –
Purple Biotech net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -$26.39M. The highest annual figure on record is $28.00M in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$26.39M | – |
| FY2024 | Dec 31, 2024 | -$7.24M | – |
| FY2023 | Dec 31, 2023 | -$19.88M | – |
| FY2022 | Dec 31, 2022 | -$21.67M | -217.9% |
| FY2021 | Dec 31, 2021 | $18.38M | -34.3% |
| FY2020 | Dec 31, 2020 | $28.00M | +378.6% |
| FY2019 | Dec 31, 2019 | $5.85M | +12.5% |
| FY2018 | Dec 31, 2018 | $5.20M | -57.3% |
| FY2017 | Dec 31, 2017 | $12.18M | +0.4% |
| FY2016 | Dec 31, 2016 | $12.13M | +188.6% |
| FY2015 | Dec 31, 2015 | $4.20M | – |
See a number that looks wrong?